Author:
Pothuri B.,Blank S.V.,Myers T.K.,Hines J.F.,Randall L.M.,O'Cearbhaill R.E.,Slomovitz B.M.,Eskander R.N.,Alvarez Secord A.,Coleman R.L.,Walker J.L.,Monk B.J.,Moore K.N.,O'Malley D.M.,Copeland L.J.,Herzog T.J.
Subject
Obstetrics and Gynecology,Oncology
Reference54 articles.
1. Racial and ethnic differences in hysterectomy-corrected uterine corpus cancer mortality by stage and histologic subtype;Clarke;JAMA Oncol.,2022
2. Herrraez AC Lenvatinib plus Pembrolizumab for advanced endometrial cancer;Makker;N. Engl. J. Med.,2022
3. Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry;U.S. Food and Drug Administration,2022
4. National Institutes of Health Revitalization Act of1993: Act to Amend the Public Health Service Act to Revise and Extend the Programs of the National Institutes of Health, and for Other Purposes;US Congress,1993
5. Race/ethnicity reporting and representation in US clinical trials: a cohort study;Turner;Lancet Reg. Health- Am.,2022
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献